Australia: Sonic investing A$17.8m for 20% stake in Microba Life Sciences

Sonic Healthcare, one of the world’s largest medical diagnostics companies and second largest healthcare company on ASX, has agreed to invest A$17.8m (US$12m) to acquire a 19.99% shareholding in Microba Life Sciences. Microba Life Sciences is a precision microbiome company with technology for measuring the human gut microbiome. Shares are to be acquired at A$0.26….

You must be a HMI Subscriber to view this content.

Subscribe Now »